
October 1 from 3 to 4 PM | Network Hyperexcitability in Alzheimer's Disease: An Early Intervention Opportunity
Network Hyperexcitability in Alzheimer's Disease: An Early Intervention Opportunity A scientific seminar by Dr. Keith V…
Network Hyperexcitability in Alzheimer's Disease: An Early Intervention Opportunity A scientific seminar by Dr. Keith V…
Astrid M. Suchy-Dicey, PhD, chair and
scientific director of Clinical and Translational Neuroscience and principal…
The abstract, Endothelial GABAA Receptor Signaling Modulates Postnatal Brain Development, from the Angiogenesis and Brai…
The abstract, Detection of Ketone Bodies as Biomarkers of Cognitive Function from the Biomarker and Neuor-disease Mechan…
Alfred N. Fonteh, PhD, head of the Biomarker Neuro-disease Mechanism Laboratory and Joby Jose, PhD, postdoctoral researc…
Robert A. Kloner, MD, PhD,HMRI's chief science officer and chair of Cardiovascular Research, and professor medicine (cli…
HMRI Clinical and Translational Neuroscientist, Alfred N. Fonteh, PhD was published in Alzheimer's & Dementia: The J…
HMRI's Chief Science Officer and Chair of Cardiovascular Research, Robert A. Kloner, MD, PhD was published in Mayo Clini…
President and CEO, Julia E. Bradsher, PhD, MBA moderated a panel discussion as part of HMRI's Annual Science Day on July…
President and CEO, Julia E. Bradsher, PhD, MBA moderated a panel discussion on November 6, 2024 highlighting current tre…
Network Hyperexcitability in Alzheimer's Disease: An Early Intervention Opportunity A scientific seminar by Dr. Keith V…
ABOUT THE SPEAKER: The Biomarkers Neuro-Disease Mechanism Lab (BNML) is led by Alfred Fonteh, PhD, who has investigated…
Astrid M. Suchy-Dicey, PhD, chair and scientific director of Clinical and Translational Neuroscience and principal inves…
Abdulhakim Al-Ezzi, PhD, postdoctoral research scholar of Cognition and Brain Integration Laboratory presented the Bob M…
July 23, 2025 HMRI scientists and the 2025 cohort of students present their research to the public. Details Coming Soon